Why the study?
Does prophylactic anticoagulation with heparin and aspirin prevent pregnancy complications in pregnant women with inherited thrombophilias or antiphospholipid syndrome?
Does prophylactic anticoagulation with heparin and aspirin prevent pregnancy complications in pregnant women with inherited thrombophilias or antiphospholipid syndrome?
Answers are grounded in this paper and cite their sources.
This review highlights the ongoing debate regarding anticoagulation in pregnancy, noting potential benefits of heparins for late-term losses in inherited thrombophilias while optimal management remains uncertain.
The role of anticoagulants in the prevention of pregnancy complications, including recurrent miscarriage, late fetal loss, and preeclampsia, continues to be an area of active research and debate. Although prophylactic anticoagulation with heparin and aspirin is considered the standard of care in some conditions, such as obstetric antiphospholipid antibody syndrome, the optimal management of pregnant women with factor V Leiden mutation, prothrombin G20210A mutation, and other inherited thrombophilias without a history of thrombosis remains unknown. Some studies suggest a benefit of heparins in preventing late-term losses but not earlier miscarriages in the inherited thrombophilias. In the following review, we will discuss the recent literature regarding anticoagulation and pregnancy complications and conclude with our suggested approach to the management of these challenging patients.
No takes yet. Share an insight, caveat, or question.
Leaf et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: